Eye Surgery Clinics in Australia: Market Size, Businesses & Forecast 2026

The Eye Surgery Clinics industry in Australia comprises specialized medical facilities focused on diagnostic, therapeutic, and elective ophthalmic surgical interventions, including cataract removals, laser vision correction, and retinal surgeries. The sector operates as a critical component of the broader Australian healthcare ecosystem, handling substantial caseloads such as the 957,933 Medicare claims registered for ophthalmic operations in 2017-18 (Australian Institute of Health and Welfare). The industry is experiencing steady structural demand driven by an aging demographic, with long-term vision disorders affecting approximately 93% of Australians aged 65 and over during the 2017-18 da

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Eye Surgery Clinics in Australia industry cover?

This industry encompasses standalone day surgeries, dedicated private ophthalmology clinics, and specialized non-profit medical institutes that primarily perform surgical operations on the eye and its adnexa. Core clinical activities include refractive laser procedures (such as LASIK, PRK, and SMILE), elective cataract removals, glaucoma drainage implantations, and vitreoretinal operations. These specialized facilities provide localized outpatient care, bridging the gap between general optometry practices and broad-spectrum acute-care public hospitals.

• •Primary services focus on major vision-impairment corrections, notably targeting cataracts, uncorrected refractive errors, and age-related macular degeneration.
• •Procedures are largely performed on an outpatient or day-surgery basis, optimizing patient throughput and recovery times.
• •The scope excludes general optometry, retail optical dispensing, and long-term inpatient psychiatric or residential aged care.

Who operates in the industry and how is it structured?

The Australian market structure is characterized by a mix of large corporate clinical groups, highly integrated non-profit research institutes, and independent localized private partnerships. Corporate entities have consolidated multiple individual practitioner clinics to leverage back-end efficiencies, centralized procurement, and co-located day hospitals. Simultaneously, charitable and research-backed institutes maintain a strong footprint, particularly in Western Australia and Queensland, balancing public health objectives with private patient services.

• •Private clinical corporate networks dominate metropolitan centers, bundling diagnostic clinics with day hospitals.
• •Non-profit and research-integrated institutes manage high patient volumes while simultaneously facilitating advanced clinical trials and tertiary medical education.
• •Regional and remote service delivery relies heavily on a hybrid model of public hospital access, telehealth infrastructure, and mobile clinical vans.

What drives demand in the industry?

The primary catalyst for industry growth is Australia's shifting demographic profile, characterized by an accelerating aging population that naturally requires higher rates of ocular care. Furthermore, public funding mechanisms through Medicare and private health insurance rebates substantially lower the financial barriers for elective and essential surgical interventions. Increased societal screen usage and rising rates of chronic conditions like diabetes also elevate the prevalence of complex retinal and refractive disorders.

• •Demographic tracking reveals that over 13 million Australians live with at least one chronic vision disorder.
• •Age stands as the most critical factor, with the prevalence of vision disorders climbing rapidly to impact 93% of individuals aged 65 and older.
• •Comorbidities influence surgical demand, highlighted by a rising volume of patients requiring specialized diabetic retinopathy monitoring and interventions.

Who are the notable companies in the industry?

Competition within the industry centers on clinical reputation, technology ownership, geographical accessibility, and the recruitment of highly specialized ophthalmic surgeons. Major operators strive to secure market share by installing advanced diagnostic imaging and proprietary laser systems across strategic metropolitan hubs. While many operators are private or non-profit entities, the landscape features corporate structures backed by international investment or dedicated foundations.

• •Vision Eye Institute operates as Australia's largest private provider of ophthalmic care, overseeing a network of 19 consulting clinics and 11 day surgeries under Vision Hospital Group.
• •Lions Eye Institute functions as a major non-profit clinical and research group, treating approximately 60,000 patients annually across multiple Western Australian centers.
• •Queensland Eye Institute delivers specialized care to over 12,500 patients annually through its integrated day hospital and clinical infrastructure.
• •PersonalEYES maintains a prominent regional presence with 10 state-of-the-art vision correction clinics established across New South Wales and the Australian Capital Territory.

What are the recent trends and outlook?

Technological evolution represents the core trend shaping the sector, marked by the rapid adoption of minimally invasive glaucoma surgery devices and advanced femtosecond lasers. Clinics are increasingly integrating artificial intelligence and digital diagnostic screening platforms to streamline patient workflows and enhance diagnostic accuracy for macular diseases. The long-term outlook remains strong as public-sector waiting lists encourage patients to transition to private day surgeries for faster elective outcomes.

• •Clinics are continually introducing next-generation surgical solutions, including micro-shunts to manage intraocular pressure and advanced cross-linking technology for corneal conditions.
• •The historical median wait time for elective public cataract surgery sat at 118 days for non-Indigenous patients, driving consistent private clinic diversion.
• •Clinical operating models are increasingly emphasizing same-day discharge and advanced topical local anesthetics to maximize efficiency.

How is the industry regulated?

Operating an eye surgery clinic in Australia mandates adherence to strict federal and state medical regulatory frameworks ensuring patient safety and clinical efficacy. Ophthalmic surgeons must be registered with the Medical Board of Australia and maintain active fellowship with the Royal Australian and New Zealand College of Ophthalmology. Furthermore, any surgical hardware, intraocular lenses, or pharmaceuticals utilized during procedures must be rigorously evaluated and approved for clinical use.

• •The Therapeutic Goods Administration controls the entry of all medical devices, such as intraocular lenses and laser technologies, into the Australian market.
• •Day hospitals and surgical suites are obligated to maintain formal accreditation against the National Safety and Quality Health Service Standards.
• •Public health frameworks are heavily focused on reducing systemic inequities, specifically targeting specialized eye health measures for Aboriginal and Torres Strait Islander communities.

Government, statistical and trade sources used for this Claight analysis.

• Australian Bureau of Statistics 2006 (Revision 2.0) ·
• Australian Institute of Health and Welfare Eye Health Measures 2025 ·
• Australian Government Department of Health, Disability and Ageing ·
• Therapeutic Goods Administration (TGA)